Clinical Trial

A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet)

Name: A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet) — clinical trial record (NCT07613424)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Genomet

Recruiting

View on ClinicalTrials.gov →

Summary

Multicenter prospective assessment of MET concordance and tumor gene profiling in treatment-naïve NSCLC

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-16

Trial Details

NCT Number	NCT07613424
Lead Sponsor	AstraZeneca
Conditions	Non-Small Cell Lung Cancer
Enrollment	1,000 participants
Start Date	2026-06-02
Primary Completion	2027-03-31 (estimated)
Study Completion	2027-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-14